BRD4 p.Ala565Val
c.1694C>T · rs971737368 · VCV2352746
Computational evidence
| Protein change | ||
| AlphaMissense | 0.0703 | likely benign |
|---|---|---|
| REVEL | 0.083 | moderately benign-leaning |
| SaProt | LLR -5.43 | tolerated |
| ⇒ AlphaMissense, REVEL and SaProt all call this tolerated. | ||
| Splicing | ||
| SpliceAI | <0.2 | all four deltas below 0.2 · G>C here scores Δ0.31 · evaluated, not missing |
| Constraint at this position | ||
| Conservation | phyloP 9.8 | GERP 2.3, phastCons 1 |
| Regional constraint | o/e 1.09 | unconstrained · MANE · 672 bp · p 0.42 · regional, not allelic |
| Overall | ||
| CADD | 23.1 | PHRED · no single calibrated threshold — expert panels disagree |
ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Remaining individualsnot grpmax-eligible | 0.00963% | 10,382 |
| East Asiangrpmax | 0.00446% | 22,446 |
Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- BRD4
- Protein
- p.Ala565Val
- Coding
- c.1694C>T
- MANE Select
- NM_001379291
- dbSNP
- rs971737368
- Type
- single nucleotide variant
- Location
- chr19:15256121 (GRCh38)
- Gene constraint
- LOEUF 0.191 · pLI 1.00 (gnomAD)
- Structure
- AlphaFold pLDDT 56.20 · 613 PDB
- Residue 565
- a UniProt-annotated variant site (found in a patient with a neurodevelopmental syndrome; likely pathogenic); the 'disordered' region; the 'bid region' region
Similar variants
- BRD4 p.Ala220Thr Uncertain significance ★★ ⚠ same condition
- BRD4 p.Ala409Thr Uncertain significance ★★ ⚠ same condition
- BRD4 p.Asp497Gly Uncertain significance ★★ ⚠ same condition
- BRD4 p.Gln32Arg Uncertain significance ★★ ⚠ same condition
- BRD4 p.Glu715Lys Uncertain significance ★★ ⚠ same condition
- BRD4 p.Glu718Gln Uncertain significance ★★ ⚠ same condition
- BRD4 p.Gly6Ala Uncertain significance ★★ ⚠ same condition
- BRD4 p.Ile300Val Uncertain significance ★★ ⚠ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/brd4-p-ala565val (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown